<DOC>
	<DOCNO>NCT02472613</DOCNO>
	<brief_summary>This multicentre , single Blind , randomize control clinical trial ischemic post-stroke depression patients.The participant allocate randomly either two group : verum acupuncture plus placebo medication group sham acupuncture plus true medication group . On hypothesis acupuncture intervention could produce therapeutic effect antidepressant . The investigator also hypothesize acupuncture would associate minimal side effect .</brief_summary>
	<brief_title>Acupuncture Ischemic Post-stroke Depression</brief_title>
	<detailed_description>Aim : To observe curative effect acupuncture treatment Ischemic Post－Stroke Depression． Design : A multicentre , open-label randomize control trial perform Tianjin Beijing . Two hundred eight participant Ischemic Post-Stroke Depression patient randomly divide two group give basic treatment stroke . The acupuncture group give Tiaoshenkaiqiao acupuncture therapy placebo，while control group treat fluoxetine tablet sham acupoint acupuncture treatment . Evaluated clinical efficacy two group Hamilton Depression Scale ( HAMD ) , Barthel Index ( BI ) , Treatment Emergent Symptom Scale , ( TESS ) , Clinical Global Impression Scale ( CGI ) respectively treatment , second weekend treatment , fourth weekend treatment , eighth weekend treatment , twelfth weekend treatment . And observe adverse reaction two group . Each participant receive 36 session acupuncture 12 week , duration 30 minute session . After treatment accomplish , one follow-up 24th week .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Fluoxetine</mesh_term>
	<criteria>accordance diagnosis ischemic stroke International Classification Diseases—10 163 , （ICD10 163） ; diagnosis major depressive episode accord depression module Structured Clinical Interview Diagnostic Statistical Manual Mental DisordersIV （DSMIV）or Chinese Classification Diagnostic Criteria Mental Disorders3 ( CCMD3 ) age subject 40 80 year old , male female ; recently experience ischemic poststroke depression recent ( &lt; 6 month ) ; conscious , examination cooperation , without aphasia severe cognitive impairment ; capacity provide write consent research assessment treatment . participation clinical trial within previous take antidepressant treatment 2 week prior baseline ; presence severe cognitive dysfunction , indicate Minimental State Examination ( MMSE ) score &lt; 17 presence severe aphasia ; history psychiatric illness depression impair hepatic , renal function. , hematological system ; cooperate treatment ; pregnant woman woman lactation presence another chronic disorder , include chronic alcoholism durg abuse</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Post－Stroke Depression</keyword>
	<keyword>Acupunture</keyword>
	<keyword>Fluoxetine</keyword>
	<keyword>RCT</keyword>
</DOC>